Related Experiment Video
Updated: Jun 23, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Bone disease in kidney transplant patients
Minna Huang1, Stuart M Sprague
1Division of Nephrology and Hypertension, NorthShore University HealthSystem, Northwestern University Feinberg School of Medicine, Evanston, IL, USA.
Managing bone disease after a kidney transplant is challenging due to its complex causes. Current treatments may improve bone density but not always reduce fracture risk in kidney disease patients.
Area of Science:
- Nephrology
- Endocrinology
- Bone Metabolism
Background:
- Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) severely disrupt bone and mineral metabolism.
- Posttransplantation bone disease (PTBD) is a significant complication in long-term kidney transplant survivors.
Purpose of the Study:
- To highlight the challenges in managing PTBD.
- To underscore the importance of evaluating and managing PTBD in post-transplant care.
Main Methods:
- Review of current understanding of PTBD pathophysiology.
- Analysis of therapeutic options and their impact on bone mineral density and fracture risk.
Main Results:
- PTBD management is complicated by its complex pathophysiology.
- Therapeutic interventions may improve bone mineral density but not consistently reduce fracture risk.
Conclusions:
- Effective evaluation and management of PTBD are crucial components of post-kidney transplant care.
- Further research is needed to identify treatments that effectively decrease fracture risk in these patients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Chronic Kidney Disease I: Introduction